Updated: NHS England halts cancer drugs working group

Bruce Keogh

A group tasked by NHS England to examine how cancer drugs can be evaluated and commissioned in future has had its work ‘paused’ after just six months in operation.

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here